Patent №
US 11,733,249
Granted
2023-08-22
Filed 2018
Owner
20/20 GENESYSTEMS, INC.
Lab
—
AI components
1
kr
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
16186953
A method of data interpretation from a multiplex cancer assay is described. The aggregate normalized score from the assay is transformed to a quantitative risk score quantifying a human subject's increased risk for the presence of cancer as compared to the known prevalence of the cancer in the population before testing the subject.
AI classification
Ownership
20/20 GENESYSTEMS, INC.
assignment · 474750961
Assignors
LEBOWITZ, MICHAEL, SHORE, RONALD
On an employer assignment, the assignors are typically the inventors.